Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16


Apoptotic Pathways Linked to Endocrine System as Potential Therapeutic Targets for Benign Prostatic Hyperplasia.

Minutoli L, Rinaldi M, Marini H, Irrera N, Crea G, Lorenzini C, Puzzolo D, Valenti A, Pisani A, Adamo EB, Altavilla D, Squadrito F, Micali A.

Int J Mol Sci. 2016 Aug 11;17(8). pii: E1311. doi: 10.3390/ijms17081311. Review.


Modern extraction techniques and their impact on the pharmacological profile of Serenoa repens extracts for the treatment of lower urinary tract symptoms.

De Monte C, Carradori S, Granese A, Di Pierro GB, Leonardo C, De Nunzio C.

BMC Urol. 2014 Aug 11;14:63. doi: 10.1186/1471-2490-14-63. Review.


Specialty supplement use and biologic measures of oxidative stress and DNA damage.

Kantor ED, Ulrich CM, Owen RW, Schmezer P, Neuhouser ML, Lampe JW, Peters U, Shen DD, Vaughan TL, White E.

Cancer Epidemiol Biomarkers Prev. 2013 Dec;22(12):2312-22. doi: 10.1158/1055-9965.EPI-13-0470. Epub 2013 Aug 5.


The effect of increasing doses of saw palmetto fruit extract on serum prostate specific antigen: analysis of the CAMUS randomized trial.

Andriole GL, McCullum-Hill C, Sandhu GS, Crawford ED, Barry MJ, Cantor A; CAMUS Study Group.

J Urol. 2013 Feb;189(2):486-92. doi: 10.1016/j.juro.2012.09.037. Epub 2012 Dec 14.


Association between use of specialty dietary supplements and C-reactive protein concentrations.

Kantor ED, Lampe JW, Vaughan TL, Peters U, Rehm CD, White E.

Am J Epidemiol. 2012 Dec 1;176(11):1002-13. doi: 10.1093/aje/kws186. Epub 2012 Nov 8.


Benign prostatic hyperplasia: from bench to clinic.

Yoo TK, Cho HJ.

Korean J Urol. 2012 Mar;53(3):139-48. doi: 10.4111/kju.2012.53.3.139. Epub 2012 Mar 19.


Biological effect of human serum collected before and after oral intake of Pygeum africanum on various benign prostate cell cultures.

Larré S, Camparo P, Comperat E, Boulbés D, Haddoum M, Baulande S, Soularue P, Costa P, Cussenot O.

Asian J Androl. 2012 May;14(3):499-504. doi: 10.1038/aja.2011.132. Epub 2011 Dec 26.


Serenoa repens extract in the treatment of benign prostatic hyperplasia.

Geavlete P, Multescu R, Geavlete B.

Ther Adv Urol. 2011 Aug;3(4):193-8. doi: 10.1177/1756287211418725.


Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial.

Barry MJ, Meleth S, Lee JY, Kreder KJ, Avins AL, Nickel JC, Roehrborn CG, Crawford ED, Foster HE Jr, Kaplan SA, McCullough A, Andriole GL, Naslund MJ, Williams OD, Kusek JW, Meyers CM, Betz JM, Cantor A, McVary KT; Complementary and Alternative Medicine for Urological Symptoms (CAMUS) Study Group.

JAMA. 2011 Sep 28;306(12):1344-51. doi: 10.1001/jama.2011.1364. Erratum in: JAMA. 2012 Jun 13;307(22):2374.


Androgens and estrogens in benign prostatic hyperplasia: past, present and future.

Nicholson TM, Ricke WA.

Differentiation. 2011 Nov-Dec;82(4-5):184-99. doi: 10.1016/j.diff.2011.04.006. Epub 2011 May 26. Review.


Effects of pumpkin seed oil and saw palmetto oil in Korean men with symptomatic benign prostatic hyperplasia.

Hong H, Kim CS, Maeng S.

Nutr Res Pract. 2009 Winter;3(4):323-7. doi: 10.4162/nrp.2009.3.4.323. Epub 2009 Dec 31.


Inhibition of inflammatory gene expression in keratinocytes using a composition containing carnitine, thioctic Acid and saw palmetto extract.

Chittur S, Parr B, Marcovici G.

Evid Based Complement Alternat Med. 2011;2011:985345. doi: 10.1093/ecam/nep102. Epub 2011 Jun 8.


Serenoa repens for benign prostatic hyperplasia.

Tacklind J, MacDonald R, Rutks I, Wilt TJ.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD001423. doi: 10.1002/14651858.CD001423.pub2. Review. Update in: Cochrane Database Syst Rev. 2012;12:CD001423.


Inflammation and benign prostatic hyperplasia.

Nickel JC.

Urol Clin North Am. 2008 Feb;35(1):109-15; vii. Review.


Discovery and therapeutic promise of selective androgen receptor modulators.

Chen J, Kim J, Dalton JT.

Mol Interv. 2005 Jun;5(3):173-88. Review.

Supplemental Content

Support Center